MEDICURE INC (MCUJF) Form 6-K — May 21, 2026
Medicure Inc. reported first-quarter 2026 results showing total net revenue of CAD 7.9 million, a 45% increase from CAD 5.4 million in the same period last year. The growth was primarily driven by ZYPITAMAG sales, which reached CAD 2.3 million, and the Pharmacy Business Segment, which contributed CAD 5.7 million following the acquisitions of Gateway Medical Pharmacy and West Olympia Pharmacy. The company recorded a net loss of CAD 406,000 (CAD 0.04 per share), a significant improvement from the CAD 694,000 loss (CAD 0.07 per share) in Q1 2025.
Key figures
- Revenue
- 7947000
- Revenue Yoy
- 45%
- Cash Position
- 1542000
- Currency
- CAD
- Rd Expenditure
- 855000
- Adjusted Ebitda
- 280000
- Aggrastat Revenue
- 979000
- Zypitamag Revenue
- 2300000
- Pharmacy Segment Revenue
- 5700000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.